BioNexus Gene Lab Corp SEC filings BGLC
BioNexus Gene Lab Corp has 157 filings in SEC EDGAR's recent list, going back to Jan 29, 2019. Its latest annual report, Form 10-K, was filed on Apr 14, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 7, 2026 (material agreement, unregistered share sale, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Oct 7, 2026 | Oct 5, 2026 |
| 8-K |
Current report
Other events
|
Jul 28, 2026 | Jul 28, 2026 |
| 8-K |
Current report
Other events
|
Jun 5, 2026 | May 29, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 17, 2026 | Mar 11, 2026 |
| 8-K |
Current report
Other events
|
Feb 23, 2026 | Feb 23, 2026 |
| 8-K |
Current report
Other events
|
Feb 3, 2026 | Jan 28, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Dec 30, 2025 | Dec 24, 2025 |
| 8-K |
Current report
Other events
|
Dec 23, 2025 | Dec 19, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Dec 2, 2025 | Nov 28, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Nov 13, 2025 | Nov 7, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Nov 12, 2025 | Nov 12, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 23, 2025 | Oct 20, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 30, 2025 | Jul 30, 2025 |
| 8-K |
Current report
Officer or director change
|
Jun 23, 2025 | Jun 17, 2025 |
| 8-K |
Current report
Listing notice, Regulation FD disclosure
|
Apr 30, 2025 | Apr 30, 2025 |
| 8-K |
Current report
Change to shareholder rights
|
Apr 10, 2025 | Apr 7, 2025 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Apr 3, 2025 | Apr 1, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Mar 25, 2025 | Mar 19, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 7, 2025 | Mar 7, 2025 |
| 8-K |
Current report
Other events
|
Mar 5, 2025 | Mar 5, 2025 |
| 8-K |
Current report
Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change
|
Feb 14, 2025 | Feb 11, 2025 |
| 8-K |
Current report
Listing notice
|
Jan 2, 2025 | Dec 27, 2024 |
| 8-K |
Current report
Listing notice, Officer or director change
|
Nov 8, 2024 | Nov 5, 2024 |
| 8-K |
Current report
Officer or director change
|
Oct 15, 2024 | Oct 9, 2024 |
| 8-K |
Current report
Shareholder vote results, Other events
|
Oct 10, 2024 | Oct 4, 2024 |
| 8-K |
Current report
Material agreement, Other events
|
Sep 25, 2024 | Sep 23, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 18, 2024 | Sep 14, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 12, 2024 | Sep 11, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Sep 5, 2024 | Sep 4, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 28, 2024 | Aug 27, 2024 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure, Other events
|
Aug 26, 2024 | Aug 26, 2024 |
| 8-K/A |
Amended current report
Officer or director change
|
Jul 5, 2024 | Mar 26, 2024 |
| 8-K |
Current report
Listing notice
|
May 9, 2024 | May 8, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Apr 18, 2024 | Apr 18, 2024 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Apr 1, 2024 | Mar 26, 2024 |
| 8-K |
Current report
Listing notice
|
Nov 13, 2023 | Nov 6, 2023 |
| 8-K |
Current report
Officer or director change
|
Nov 3, 2023 | Oct 30, 2023 |
| 8-K/A |
Amended current report
Officer or director change
|
Oct 30, 2023 | Oct 12, 2023 |
| 8-K |
Current report
Officer or director change
|
Oct 16, 2023 | Oct 12, 2023 |
| 8-K |
Current report
Officer or director change
|
Oct 11, 2023 | Oct 4, 2023 |
| 8-K |
Current report
Officer or director change
|
Sep 7, 2023 | Sep 7, 2023 |
| 8-K |
Current report
Material agreement, Bylaw or fiscal year change
|
Jul 24, 2023 | Jul 24, 2023 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Jul 20, 2023 | Jul 20, 2023 |
| 8-K |
Current report
Officer or director change
|
Aug 15, 2022 | Aug 9, 2022 |
| 8-K/A |
Amended current report
Material agreement, Acquisition or sale of assets
|
Mar 11, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change in control
|
Jan 7, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Material agreement
|
Dec 30, 2020 | Dec 24, 2020 |
| 8-K |
Current report
Other events
|
Dec 22, 2020 | Dec 17, 2020 |
| 8-K |
Current report
Officer or director change
|
Dec 10, 2020 | Nov 27, 2020 |
| 8-K |
Current report
Auditor change
|
Oct 8, 2020 | Oct 1, 2020 |
| 8-K |
Current report
Material agreement
|
Oct 15, 2019 | Oct 1, 2019 |
Showing 51 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Services-Medical Laboratories (SIC 8071)
- Listed as
- BGLC (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- WY
- Headquarters
- Kuala Lumpur
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1737523
- Former names
- BioNexus Gene Lab Coporation (until May 8, 2020)
Other Services-Medical Laboratories companies
- Natera, Inc. NTRA
- Labcorp Holdings Inc. LH
- Quest Diagnostics Inc DGX
- Guardant Health, Inc. GH
- Caris Life Sciences, Inc. CAI
- GRAIL, Inc. GRAL
- RadNet, Inc. RDNT
- BillionToOne, Inc. BLLN
Source: SEC EDGAR filings. This is company-reported data, not investment advice.